The Scientific Program includes 14 Plenary Sessions:

Plenary Sessions on Monday, September 11, 2023

P1 Complementary approaches to stress related diseases: connecting multi-site imaging, experimental imaging, machine learning and epigenetics

(Symposium of the Max-Planck-Institut für Psychiatrie, Munich, Germany)

Chair: Philipp Sämann und Angelika Erhardt-Lehmann

  1. ENIGMA & Hippocampal Subfields, Philipp Sämann
  2. Brain Age & MDD, Nahid Taheri
  3. Imaging Stress Test, Mira Erhart
  4. Anxiety and Epigenetics, Angelika Erhardt-Lehmann

P2 Challenges and perspectives in the treatment of anxiety disorders – a clinical update

(Symposium of the Gesellschaft für Angstforschung e.V., Wasserburg am Inn, Germany)

Chair: Peter Zwanzger and Borwin Bandelow

  1. Pharmacotherapy of anxiety disorders – the new guidelines of the WFSBP, Borwin Bandelow
  2. Anxiety, sleep and stress, Martin Hatzinger
  3. Digital approaches in the treatment of anxiety disorders – opportunities and limitations, Peter Zwanzger
  4. Anxiety and the COVID-19 pandemic, Antonia Bendau

P3 Stress in neurological conditions (Dr. med Edda Neele-Stiftung Symposium)

Chair: Peter Riederer and Thomas Brücke

  1. Is ADHD a risk for Alzheimer’s and Parkinson’s disease? Linked via oxidative stress and inflammation? Edna Grünblatt
  2. MSA, a multiple stress disorder, Gregor Wenning
  3. BPS in dementia, Jens Benninghoff
  4. TBA

P4 Women & Stress

Chair: Birgit Derntl and Andreas Fallgatter

  1. Stress hormone dynamics and reproductive states, Vibe Frokjaer
  2. Hormonal contraception and stress reactivity, Birgit Derntl
  3. Exposure to childhood maltreatment and systemic inflammation across pregnancy: the role of psychological and physical sequelae of maltreatment, Theresa Kleih
  4. TBA

P5 Psychobiological mechanisms of social stress and social buffering

Chair: Beate Ditzen and TBA

  1. A minimal couple intervention to improve stress resilience: Neuroendocrine and immunological findings, Beate Ditzen
  2. Social buffering in virtual reality and real life, Grit Hein
  3. TBA
  4. TBA

P6 Stress, Anxiety and Covid-19

Chair: Christian Jacob and TBA

  1. Invited lecture
  2. Predicting stress, fatigue, mood, and hair cortisol in two COVID-19 lockdowns, Aljoscha Dreisörner
  3. TBA
  4. TBA


Plenary Sessions on Tuesday, September 12, 2023

P7 ADHD and stress under different perspectives, what we can learn from translational research

Chair: Stefano Pallanti and Susanne Walitza

  1. Oxidative stress and inflammation in ADHD? Personalized in vitro modeling and treatments effects, Edna Grünblatt
  2. Emotional dysregulation in ADHD, and treatment outcome. A summary of the evidence, Stefano Pallanti
  3. Climate change impact on ADHD? Thomas Müller
  4. TBA

P8 Primary and secondary prevention of youth suicide

Chair: Gregor Berger and TBA

  1. Trajectories of suicidal ideation in children and adolescents with major depressive disorder, Isabelle Häberling
  2. Early detection and prevention of mental health problems in school settings, Daniel Frey
  3. Suicide prevention programs in the state of Zurich, Martina Blaser
  4. AdoSSIP – A short intervention program for youth after suicide attempts, Gregor Berger

P9 Zurich translates Stress: New findings on understanding and treating stress from the HMZ flagship project STRESS

Chair: Johannes Bohacek and Birgit Kleim

  1. Unsupervised profiling of stress-induced behavioral changes in rodents, Johannes Bohacek
  2. Neural emotion-regulation development and stress: A two-way street, Nora Raschle & Mirjam Habegger
  3. Resilience in the face of stress: Investigating the neurobiological correclates of emotional conflict and arousal in a preregistered prospective cohort study, Laura Meine & Ella McPherson
  4. Modulating arousal: what we have learned – and still have to learn – from pupil-based feedback, Sarah Meissner

P10 Anxiety, depression and loneliness

Chair: Jens Benninghoff and Andreas Menke

  1. Depression and anxiety in the elderly, Jens Benninghoff
  2. How to deal with treatment resistent depression? Therapeutic drug monitoring, pharmacogenetics and rapid-acting antidepressants, Andreas Menke
  3. TBA
  4. TBA

P11 Stress and psychological trauma: Risk and mechanisms for multiple health conditions

Chair: Mustafa al´Absi and Roland von Känel

  1. Impact of traumatic stress and early life adversity on addiction and relapse: Biobehavioral mechanisms and therapeutic implications, Mustafa al´Absi
  2. Posttraumatic stress disorder induced by cardiac disease, Roland von Känel
  3. Anxiety and stress in the perspective of psychocardiology, Malte Meesmann
  4. TBA

P12 Everyday Life Stress

Chair: Urs Nater and Andreas Schwerdtfeger

  1. Are cumulative episodes of non-metabolic reductions in heart rate variability in daily life informative of a person’s mental health? Andreas Schwerdtfeger
  2. Examining fatigue and chronic stress in adults: From lab to life, Nida Ali
  3. TBA
  4. TBA

Plenary Sessions on Wednesday, September 13, 2023

P13 New insights in aetiology and therapy of anxiey, depression and stress related disorders (Symposium of the SGAD)

Details on the symposium and summary of the lectures

Chair: Annette Brühl and TBA

  1. Environmental factors in offspring of parents with mood disorders and their role in parent–child transmission: findings from a 14 year prospective high risk study, Martin Preisig
  2. Biomarker-guided antidepressant therapy, Martin Hatzinger
  3. Brain Stimulation in stress-related, anxiety and affective disorders – an overview, Annette Brühl
  4. TBA

P14 Telemedicine

Chair: Tobias Renner and Karsten Hollmann

  1. Sensor-based detection of stress and anxiety in telemedical treatment of children and adolescents with obsessive-compulsive disorder (SSTeP-KiZ), Carolin Klein
  2. Computational Affect and Behavior Recognition in the Context of Pediatric Obsessive-Compulsive Disorder, Nicole Nadine Lønfeldt
  3. TBA
  4. TBA